{
  "question_stem": {
    "en": "A 68-year-old man comes to the emergency department due to lightheadedness, generalized weakness, and palpitations. The patient has a prolonged history of hypertension and takes amlodipine. He does not use tobacco or alcohol. His blood pressure is 110/60 mm Hg and pulse is 144/min and irregular. ECG {{exhibit_1}} shows an irregularly irregular rhythm and absent P waves. The patient is started on beta blocker therapy for rate control, with improvement in his heart rate. Long-term anticoagulation is initiated to prevent atrial thrombus formation, and he is eventually discharged home on warfarin.",
    "zh": "一名68岁男性因头晕、全身无力和心悸来急诊就诊。患者有高血压病史，服用氨氯地平。他不吸烟也不饮酒。他的血压为110/60 mm Hg，脉搏为144/min且不规则。心电图{{exhibit_1}}显示不规则心律和P波消失。患者开始接受β受体阻滞剂治疗以控制心率，心率有所改善。开始长期抗凝治疗以预防心房血栓形成，最终出院时服用华法林。"
  },
  "question": {
    "en": "Which of the following is the best test to monitor the anticoagulation effect of warfarin in this patient?",
    "zh": "以下哪项是监测该患者华法林抗凝效果的最佳检查？"
  },
  "options": {
    "A": {
      "en": "Activated partial thromboplastin time",
      "zh": "活化部分凝血活酶时间"
    },
    "B": {
      "en": "Bleeding time",
      "zh": "出血时间"
    },
    "C": {
      "en": "Fibrin split products",
      "zh": "纤维蛋白裂解产物"
    },
    "D": {
      "en": "Fibrinogen levels",
      "zh": "纤维蛋白原水平"
    },
    "E": {
      "en": "Prothrombin time",
      "zh": "凝血酶原时间"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "The patient's ECG (irregularly irregular rhythm with absent P waves) suggests ATRIAL FIBRILLATION (AF), which alters cardiac flow dynamics, making thrombus formation more common. If this thrombus detaches from the atrial wall, there is a risk of stroke. The oral anticoagulant WARFARIN (Coumadin) reduces thrombus formation risk by inhibiting the activation of vitamin K-dependent clotting factors II, VII, IX, and X (vitamin K antagonist) {{exhibit_2}}. This leads to decreased levels of these factors, particularly factor VII, and therefore prolongs the prothrombin time (PT).\n\nAnother useful laboratory value is the INTERNATIONAL NORMALIZED RATIO (INR), a ratio of the patient's PT to a control (usual INR target for AF: 2.0-3.0). Examples of indications include AF, deep venous thrombosis, and pulmonary thromboembolism. Outpatients who take warfarin typically have their INR checked every few weeks (more frequently initially).\n\nThe most common side effect is excessive anticoagulation leading to bleeding (which can require vitamin K and fresh frozen plasma if rapid reversal is needed). Skin necrosis can occur during the first few days of treatment due to a transient hypercoagulable state (reduction in protein C anticoagulant activity before affecting other factors' procoagulant activity); for this reason, heparin is typically administered temporarily at the start of warfarin therapy (\"heparin bridge\"). Warfarin should not be used during pregnancy because it is teratogenic and can cause fetal bleeding.\n\n(Choice A) Activated partial thromboplastin time (aPTT) is used to monitor unfractionated heparin, which primarily affects the intrinsic coagulation pathway.\n\n(Choice B) Bleeding time is used for the assessment of platelet function. Increased bleeding time can be seen with thrombocytopenia, von Willebrand disease, defects of platelet aggregation, disseminated intravascular coagulation (DIC), and aspirin therapy.\n\n(Choices C and D) The combination of a decreased fibrinogen level and the presence of fibrin split products (such as D-dimer) is characteristic of DIC.\n\nEducational objective:\nWarfarin is an oral anticoagulant that inhibits the carboxylation of vitamin K-dependent coagulation factors II, VII, IX, and X. It is used in atrial fibrillation, deep venous thrombosis, and pulmonary thromboembolism. Prothrombin time (PT)/International Normalized Ratio (INR) should be monitored regularly during treatment with warfarin. Activated partial thromboplastin time (aPTT) is used for monitoring unfractionated heparin.",
    "zh": "患者的心电图（不规则心律伴P波消失）提示心房颤动（AF），这改变了心脏的血流动力学，使血栓形成更常见。如果血栓从心房壁脱落，则有中风的风险。口服抗凝剂华法林（Coumadin）通过抑制维生素K依赖性凝血因子II、VII、IX和X（维生素K拮抗剂）的激活来降低血栓形成的风险{{exhibit_2}}。这导致这些因子水平降低，特别是因子VII，因此延长了凝血酶原时间（PT）。\n\n另一个有用的实验室指标是国际标准化比值（INR），它是患者PT与对照的比例（AF的常用INR目标：2.0-3.0）。适应症的例子包括AF、深静脉血栓形成和肺栓塞。服用华法林的门诊患者通常每隔几周检查一次INR（最初更频繁）。\n\n最常见的副作用是过度抗凝导致出血（如果需要快速逆转，可能需要维生素K和新鲜冰冻血浆）。在治疗的最初几天，由于短暂的高凝状态（降低蛋白C抗凝活性，然后影响其他因子的促凝活性），可能会发生皮肤坏死；因此，在华法林治疗开始时通常会暂时给予肝素（“肝素桥”）。华法林不应用于妊娠期，因为它具有致畸性，并可导致胎儿出血。\n\n（选项A）活化部分凝血活酶时间（aPTT）用于监测普通肝素，它主要影响内源性凝血途径。\n\n（选项B）出血时间用于评估血小板功能。血小板减少症、von Willebrand病、血小板聚集缺陷、弥漫性血管内凝血（DIC）和阿司匹林治疗均可见出血时间延长。\n\n（选项C和D）纤维蛋白原水平降低和纤维蛋白裂解产物（如D-二聚体）的存在是DIC的特征。\n\n教育目标：\n华法林是一种口服抗凝剂，可抑制维生素K依赖性凝血因子II、VII、IX和X的羧化。它用于心房颤动、深静脉血栓形成和肺栓塞。在华法林治疗期间，应定期监测凝血酶原时间（PT）/国际标准化比值（INR）。活化部分凝血活酶时间（aPTT）用于监测普通肝素。"
  },
  "summary": {
    "en": "This question tests knowledge of anticoagulation therapy with warfarin, specifically the mechanism of action and appropriate monitoring parameters. It requires understanding the vitamin K-dependent clotting factors and the role of prothrombin time (PT) and INR in assessing warfarin's effect. \n\nTo solve this question, recognize that warfarin inhibits vitamin K-dependent clotting factors, leading to a prolonged PT. The INR, derived from the PT, is the standard measure for monitoring warfarin's anticoagulation effect. Eliminate options related to heparin monitoring or platelet function.",
    "zh": "本题考察了华法林抗凝治疗的知识，特别是其作用机制和适当的监测参数。它要求理解维生素K依赖性凝血因子以及凝血酶原时间（PT）和INR在评估华法林疗效中的作用。\n\n要解决这个问题，需要认识到华法林抑制维生素K依赖性凝血因子，从而导致PT延长。INR源于PT，是监测华法林抗凝效果的标准指标。排除与肝素监测或血小板功能相关的选项。"
  },
  "tags": "Atrial fibrillation; Warfarin; Anticoagulation; Prothrombin time; INR; Vitamin K; Coagulation cascade; Cardiology; Hematology",
  "category": "Blood",
  "question_id": "1200",
  "has_exhibits": true,
  "exhibit_count": 2,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Blood 23\\1200",
  "extracted_at": "2025-11-05T13:22:47.515314",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:26:14.852575",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}